BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26577922)

  • 1. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.
    Herkenne S; Paques C; Nivelles O; Lion M; Bajou K; Pollenus T; Fontaine M; Carmeliet P; Martial JA; Nguyen NQ; Struman I
    Sci Signal; 2015 Nov; 8(403):ra117. PubMed ID: 26577922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
    Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
    Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
    Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.
    Beloglazova I; Stepanova V; Zubkova E; Dergilev K; Koptelova N; Tyurin-Kuzmin PA; Dyikanov D; Plekhanova O; Cines DB; Mazar AP; Parfyonova Y
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119157. PubMed ID: 34619163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
    Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
    IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.
    Sun J; Huang W; Yang SF; Zhang XP; Yu Q; Zhang ZQ; Yao J; Li KR; Jiang Q; Cao C
    Theranostics; 2018; 8(17):4695-4709. PubMed ID: 30279732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
    Tae N; Lee S; Kim O; Park J; Na S; Lee JH
    Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.
    Rahman HNA; Wu H; Dong Y; Pasula S; Wen A; Sun Y; Brophy ML; Tessneer KL; Cai X; McManus J; Chang B; Kwak S; Rahman NS; Xu W; Fernandes C; Mcdaniel JM; Xia L; Smith L; Srinivasan RS; Chen H
    Circ Res; 2016 Mar; 118(6):957-969. PubMed ID: 26879230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network trafficking.
    Jin F; Hagemann N; Brockmeier U; Schäfer ST; Zechariah A; Hermann DM
    Angiogenesis; 2013 Jul; 16(3):625-37. PubMed ID: 23429999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis.
    Park SY; Shi X; Pang J; Yan C; Berk BC
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):737-43. PubMed ID: 23393387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways.
    Law AY; Wong CK
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):73-81. PubMed ID: 23664860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
    Prager GW; Breuss JM; Steurer S; Olcaydu D; Mihaly J; Brunner PM; Stockinger H; Binder BR
    Circ Res; 2004 Jun; 94(12):1562-70. PubMed ID: 15131009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
    Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
    Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2.
    Oh MK; Park HJ; Lee JH; Bae HM; Kim IS
    FEBS Lett; 2015 Apr; 589(9):1009-17. PubMed ID: 25775978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.